Premenstrual Syndrome (PMS)
Premenstrual syndrome (PMS) is a pattern of cyclical physical, cognitive, and emotional symptoms that appear in the luteal phase of the menstrual cycle and resolve with or shortly after the onset of menses. Common features include irritability, mood lability, bloating, breast tenderness, fatigue, and difficulty concentrating. The defining characteristic is the cyclical pattern: symptoms appear predictably after ovulation and clear with menstruation.[66]
Severity exists on a spectrum. The severe end, characterized by marked mood disruption and functional impairment, meets criteria for premenstrual dysphoric disorder (PMDD) as defined by DSM-5. Distinguishing PMS from PMDD, and both from conditions that worsen premenstrually (such as perimenstrual exacerbation of a mood disorder), requires prospective symptom tracking across at least two cycles.[66]
PMS is under-characterized as a clinical entity. Conventional management has relied primarily on SSRIs and suppressive hormonal medications rather than investigation of luteal-phase physiology.[66] That approach has a consequence: if the healthy luteal phase itself has not been rigorously defined, it is not possible to specify precisely when or why it becomes abnormal. Major reproductive medicine bodies acknowledge that no diagnostic test for luteal dysfunction has proven reliably reproducible, and that defining a normal hormonal threshold for the luteal phase remains an unsolved problem.[45] PMS research sits on that same uncertain foundation. There are candidate theories; none has been established as the cause.
Progesterone is not the cause of PMS. Progesterone is a physiologic hormone produced by the corpus luteum after an ovulatory event, and it is essential to normal luteal function.[44] Framing it as the problem inverts the evidence. The more plausible drivers, supported by what is known about luteal physiology, are an abnormal decline in progesterone and/or estrogen as the cycle closes, a relative imbalance between the two hormones, corpus luteum insufficiency,[131] and systemic contributors including inflammation, insulin dysregulation, nutrient deficiencies, and stress. These are candidate mechanisms, not established causes. Individualized evaluation, rather than a uniform explanation, reflects the current state of the evidence. A controlled trial of vaginal progesterone for PMS did not separate from placebo,[67] and the literature reflects ongoing investigation rather than a single settled approach.
Cyclical premenstrual symptoms are a recognized correlate of ovulation.[220] That connection is clinically important. When the ovulatory event is compromised, whether through a corpus luteum defect[111] or inadequate luteal-phase function, the hormonal architecture of the second half of the cycle is disrupted. Luteal phase defects can occur even after apparently normal follicular development.[111] This is the context in which the cyclical pattern of PMS becomes a clinical question about ovulatory cycle quality, not simply a symptom cluster to suppress.
The cyclical pattern points directly to luteal phase function as the clinical question to investigate. Fertility charting provides the cycle-phase precision that retrospective calendar estimates cannot, allowing clinicians to correlate symptom timing precisely with hormonal phase. The peak day and post-peak phase charting markers provide the reference frame for identifying when in the cycle symptoms begin. When PMS symptoms are severe or disabling, evaluation of luteal phase deficiency and thyroid function is a logical starting point.
The PMS-to-postpartum depression connection adds another dimension. A history of PMS before pregnancy is associated with increased risk of postpartum depression, with a dose-response pattern: women reporting frequent premenstrual symptoms carry a materially higher risk, and this association holds independent of prior depression history.[248] That predictive relationship suggests shared luteal-phase and hormonal mechanisms across the reproductive lifespan, not two unrelated conditions.
Restorative approaches treat the cyclical nature of PMS as a signal worth decoding, not a symptom pattern to override. Because the luteal phase depends on a healthy ovulatory event, evaluation of ovulatory cycle quality is the starting orientation. The goal is to characterize what is happening in the second half of the cycle and address the contributing factors, rather than suppress the cycle to eliminate the signal.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.